Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes
https://www.zacks.com/stock/news/2249012/prestige-consumer-pbh-banks-on-its-portfolio-amid-cost-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2249012
Apr 02, 2024 - Prestige Consumer (PBH) develops long-term partnerships across its diverse retail footprint and invests heavily in the e-commerce channel.
0
Abbott's (ABT) i-STAT TBI Cartridge Receives FDA Approval
https://www.zacks.com/stock/news/2249322/abbott-s-abt-i-stat-tbi-cartridge-receives-fda-approval?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249322
Apr 02, 2024 - Abbott's (ABT) i-STAT Alinity instrument uses whole blood to help assess patients with a suspected mild traumatic brain injury or concussion.
0
QIAGEN (QGEN) Boosts Cancer Research Suite With New Launches
https://www.zacks.com/stock/news/2250721/qiagen-qgen-boosts-cancer-research-suite-with-new-launches?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2250721
Apr 04, 2024 - QIAGEN's (QGEN) new products, coupled with the IVD version of QIAGEN's digital PCR platform QIAcuity, are planned to be released in mid-2024.
0
Reasons to Add Cardinal Health (CAH) to Your Portfolio Now
https://www.zacks.com/stock/news/2250638/reasons-to-add-cardinal-health-cah-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2250638
Apr 04, 2024 - Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
0
Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval
https://www.zacks.com/stock/news/2251191/haemonetics-hae-new-teg-6s-cartridge-gets-fda-approval?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2251191
Apr 05, 2024 - Haemonetics' (HAE) TEG testing gives vital information that can assist doctors with better control of their patients' hemostasis.
0
Abbott (ABT) Receives FDA's Approval for the TriClip TEER System
https://www.zacks.com/stock/news/2251212/abbott-abt-receives-fda-s-approval-for-the-triclip-teer-system?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2251212
Apr 05, 2024 - Abbott (ABT) receives FDA nod for TriClip, a first-of-its-kind device to repair a leaky tricuspid heart valve.
0
Here's Why You Should Retain Penumbra (PEN) Stock for Now
https://www.zacks.com/stock/news/2252020/here-s-why-you-should-retain-penumbra-pen-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2252020
Apr 08, 2024 - Investors are optimistic about Penumbra (PEN) on strength exhibited in the Thrombectomy business and global expansion.
0
IM Cannabis (IMCC) Expands Business in Germany With New Alliance
https://www.zacks.com/stock/news/2251935/im-cannabis-imcc-expands-business-in-germany-with-new-alliance?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2251935
Apr 08, 2024 - The partnership's core objective is to grant IM Cannabis' (IMCC) subsidiary, Adjupharm GmbH, exclusive rights to introduce Avant's BLK MKT cannabis brand in Germany's medical cannabis market.
0
Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now
https://www.zacks.com/stock/news/2252692/here-s-why-you-should-retain-myriad-genetics-mygn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2252692
Apr 09, 2024 - Investors are optimistic about Myriad Genetics' (MYGN) strong solvency position and improvement in testing volume.
0
Hologic's (HOLX) New Launches Aid, Macroeconomic Issues Ail
https://www.zacks.com/stock/news/2254645/hologic-s-holx-new-launches-aid-macroeconomic-issues-ail?cid=CS-ZC-FT-analyst_blog|zer_report_update-2254645
Apr 12, 2024 - Hologic's (HOLX) Breast Health segment is gaining from a broad portfolio of solutions for breast cancer care, primarily in the burgeoning spaces of radiology, breast surgery, pathology and treatment.
0